ARCHIVES

Moffitt To Enhance Information For Brain Tumor Patients.

This article is from The Cancer Letter archive.

Vol. 27 No. 28 | July 13, 2001

Download PDF Visit The Full Archive

Related Articles

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

March 8, 2002

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

September 13, 2002

NSABP Roundup: Fisher, Pitt Negotiating; 9th Chairman Candidate

October 7, 1994

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992

Ohio Judge Fines CareToLive Prostate Cancer Group That Sought The Cancer Letter’s Confidential Source Material On Provenge.

February 29, 2008

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014